Calcineurin is subsequently involved in Alzheimer’s disease, indirectly mediating such events as tau hyperphosphorylation, synaptic plasticity, and neurotransmission decrease or neuroinflammation [44]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.